Plus Therapeutics met the listing criteria requirements for Nasdaq on August 26, 2025.
1 report, 1 independent
Updated Aug 26
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Plus Therapeutics met the listing criteria requirements for Nasdaq on August 26, 2025.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Plus Therapeutics
biopharmaceutical company
Nothing else this week.
Coverage
Newest first; wire copies grouped- GlobeNewswirePlus Therapeutics Regains Compliance with Applicable Nasdaq Listing Criteria No near-term Reverse Stock Split required to meet Bid Price Rule HOUSTON, Aug. 26, 2025 (GLOBE NEWSWIRE) -- Plus Therapeut